ATC-202

N/A

Report date: 2026/04/28 20:00:22

NME

Base Information

Drug NameATC-202

Drug Alias NameATC-202ATC202

ClassificationSmall molecules > Autophagy-Targeting Chimeras (AUTOTAC)

Mechanisms of ActionTransthyretin modulators

TargetsTransthyretin

Therapy Area/IndicationsTransthyretin amyloidosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAutotac Bio Inc

China Registration ClassN/A

Active CompaniesAutotac Bio Inc

Inactive CompaniesN/A

Active IndicationsTransthyretin amyloidosis

Inactive IndicationsN/A

ATC CodeN/A